No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Orthobiological market is a subset of the biopharmaceutical industry that focuses on the development and commercialization of products used to treat musculoskeletal conditions. These products include biologics, such as proteins, peptides, and antibodies, as well as regenerative medicines, including stem cells, platelet-rich plasma, and bone grafts. Orthobiological products are used to treat a variety of conditions, including osteoarthritis, tendon and ligament injuries, and spinal disc degeneration.
The Orthobiological market is driven by the increasing prevalence of musculoskeletal conditions, as well as the growing demand for minimally invasive treatments. Additionally, the development of new technologies, such as gene therapy and tissue engineering, has enabled the development of more effective treatments.
Some companies in the Orthobiological market include Zimmer Biomet, Stryker, Smith & Nephew, Medtronic, and DePuy Synthes. Show Less Read more
